Jenburkt Pharmaceuticals voted Awarded at Pharma Leaders Super Brand Awards 2015

MUMBAI, India - Jan. 11, 2016 - PRLog -- Jenburkt Pharmaceuticals voted by the Network 7 Media Group as "India’s Most Promising & Valuable Company 2015"

Jenburkt Pharmaceuticals selected by the Jury of Pharma Leaders Board for consistent performance at Pharma Leaders Super Brand Awards 2015 Annual Ceremony

Jenburkt Pharmaceuticals, India's fastest growing pharmaceutical company having dominant presence in the key therapeutic segments with ethical marketing network received the rare distinction at the prestigious Pharma Leaders Platform in its 2015 Annual Award Editions as "India’s Most Promising & Valuable Company 2015" at the 8th Annual Pharmaceutical Leadership Summit & Pharma leaders Business Leadership Awards 2015 on Wednesday, 30th December at  Hotel Hilton Mumbai International Airport, Mumbai, India where more than 300 power packed business tycoons, diplomats,healthcare leaders had assempled to be part of the historic debate on PHARMA LEADERS 2015 -  BRAND INDIA WINNING.

The Award Trophy & Certificate of Excellence was presented in a glittering award ceremony marked by the presence of Who's & Who's of the Indian Pharmaceutical Industry. Mr. Louis Banks who has often  been referred to as the Godfather of Indian Jazz & the iconic music composer was the Chief Guest of the evening conferred the awards with the presence of Mr.Satya Brahma, Chairman & Editor-In-Chief of Pharma Leaders Group, asia's most analytical news media in healthcare communications.

In a letter addressed to Mr. Ashish Bhuta, CMD, Jenburkt Pharmaceuticals Limited, The selection committee outlined the process of selection as "What began as an enterprise in  1985 with a single manufacturing facility at has grown into one of the biggest pharmaceutical corporate in the country, has now  blossomed into a formidable power house in pharmaceutical business in india & aiming at  much more bigger space under your dynamic leadership. Your performance under tough conditions stands out to be the most watched company in 2015. This is an outstanding growth record in indian pharma space where the indian pharmaceuticals market recorded a CAGR of 12.79 per cent in 2015 from US$ 6 billion in 2005, and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020 & By 2020, india is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size & the biggest advantage is that India’s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to India over others.

Founded in 1985, Jenburkt Pharmaceuticals is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange. Jenburkt's head quarters is located in Mumbai, from where its entire operations are handled. Jenburkt Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations in India and internationally. It offers prescription medicines in various therapeutic areas, such as anthelmintic, anti-arthritic, antibiotics, antidiabetic, anti-hypertensive, anti-inflammory analgesic, anti-malarial, anti-osteoporotic, anti-ulcerants, aphrodisiac, dermatological, gastrointenstinal, hematinics, neuropathy, and protein preparation, as well as anti-cough, cold, and allergy. The company was founded in 1985 and is based in Mumbai, India.